CCND1 and invasive breast carcinoma: Atorvastatin treatment in patients with primary invasive breast cancer led to increased protein expression of the tumor suppressor p27, lower cyclin D1 expression, and a decrease in proliferation although not significantly (p = 0.08). (NCT00816244) Feldt et al. (2015)